MediciNova holds Orphan Drug Designation for MN-166 (ibudilast) in ALS by U.S. FDA and EU EMA. MN-166 (ibudilast) has received Fast Track Designation by FDA for treatment of ALS. In addition, MN-166 ...
28 as ALS Awareness Day.Amyotrophic lateral sclerosis is a disease that attacks the nervous system, affecting nerve cells in the brain and spinal cord.Morning Traffic anchor Yasmine Julmisse ...
Researchers in the U.K. have succeeded in reverse engineering the defective cryptic splicing that drives amyotrophic lateral ...
Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...
Amyotrophic lateral sclerosis, better known as ALS, is a nervous system disease that affects nerve cells in the brain and ...
A study of around 500,000 medical records suggested that severe viral infections like encephalitis and pneumonia increase the ...
The community will gather in Jordan Valley Park on Saturday to walk in the name of an incurable disease. The ALS Association will be having its annual Walk to Defeat ALS fundraiser to raise money and ...
Modality.AI and Target ALS are partnering on a clinical study of AI as a way to assess changes in speech and motor function ...
Thought is becoming a bridge to technology. Mark, a 64-year-old American with amyotrophic lateral sclerosis (ALS), is paving ...
A participant with amyotrophic lateral sclerosis (ALS) and severe dysarthria underwent surgical implantation of ...